美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HAE 美国血液技术

交易中 07-09 13:02:29 EDT

77.17

+1.14

+1.50%

最高79.93	最低76.45	成交量40.93万
今开77.60	昨收76.03	日振幅4.58%
总市值37.07亿	流通市值36.63亿	总股本4,804万
成交额3,187万	换手率0.86%	流通股本4,746万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"美国血液技术","latestPrice":77.17,"timestamp":1752080543091,"preClose":76.03,"halted":0,"volume":409282,"delay":0,"floatShares":47462191,"shares":48041228,"eps":3.31,"marketStatus":"交易中","change":1.14,"latestTime":"07-09 13:02:29 EDT","open":77.595,"high":79.93,"low":76.45,"amount":31874124.988300003,"amplitude":0.045771,"askPrice":77.22,"askSize":106,"bidPrice":77.14,"bidSize":25,"shortable":3,"etf":0,"ttmEps":3.31,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752091200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":673761600000,"exchange":"NYSE","adjPreClose":76.03,"preHourTrading":{"tag":"盘前","latestPrice":77.04,"preClose":76.03,"latestTime":"08:19 EDT","volume":324,"amount":24944.90904,"timestamp":1752063597119},"postHourTrading":{"tag":"盘后","latestPrice":76.77,"preClose":75.97,"latestTime":"18:17 EDT","volume":39710,"amount":3018892.85,"timestamp":1752013023121},"volumeRatio":1.575533,"impliedVol":0.4083,"impliedVolPercentile":0.4},"requestUrl":"/m/hq/s/HAE","defaultTab":"news","newsList":[{"id":"2550653642","title":"美国血液技术盘中异动 大幅上涨5.21%报79.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550653642?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:41","pubTimestamp":1752068480,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时41分，美国血液技术股票出现波动，股价快速上涨5.21%。截至发稿，该股报79.93美元/股，成交量4.985万股，换手率0.10%，振幅2.33%。美国血液技术股票所在的医疗器械行业中，整体跌幅为0.11%。美国血液技术公司简介：美国血液科技公司旨在通过在血液和血浆成分采集、为手术室和医院输血服务空间提供医疗产品和解决方案，从而改善患者护理并降低医疗成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214120a69f9035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214120a69f9035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0205193047.USD","BK4198","IE00BLDYK493.USD","LU1169589451.USD","HAE","LU0106261612.USD","IE00B64QTZ34.USD","LU1169590202.USD","LU0205194284.USD","LU0012050646.USD"],"gpt_icon":0},{"id":"2549536978","title":"APGE美股盘前飙升近30%药物APG777针对特应性皮炎的试验取得积极结果；KALV大涨超15%公司HAE急性发作口服","url":"https://stock-news.laohu8.com/highlight/detail?id=2549536978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549536978?lang=zh_cn&edition=full","pubTime":"2025-07-07 18:48","pubTimestamp":1751885339,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["APGE","BK4139","BK4198","KALV","LU0205194284.USD","LU1169589451.USD","LU1169590202.USD","HAE","IE00B64QTZ34.USD","IE00BLDYK493.USD","LU0012050646.USD","LU0106261612.USD","LU0205193047.USD"],"gpt_icon":0},{"id":"2546073595","title":"Haemonetics(HAE.US)获Baird首次覆盖，给予优于大市评级, 目标价87.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546073595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546073595?lang=zh_cn&edition=full","pubTime":"2025-06-26 20:56","pubTimestamp":1750942608,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HAE","IE00BLDYK493.USD","LU0106261612.USD","IE00B64QTZ34.USD","LU0012050646.USD","LU1169590202.USD","LU0205194284.USD","BK4198","LU0205193047.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2542537853","title":"被医保支付最多的品种及背后药企。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542537853","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542537853?lang=zh_cn&edition=full","pubTime":"2025-06-11 10:38","pubTimestamp":1749609498,"startTime":"0","endTime":"0","summary":"从医保支付视角来看，医药行业的核心支付品种集中于慢性病、肿瘤、罕见病及重大疾病创新药，其背后涉及国内外药企的激烈竞争与政策协同。结合最新医保目录及行业数据，重点品种及厂家分析如下：一、糖尿病用药：医保支付规模最大品类市场规模：2024年上半年公立医疗机构口服糖尿病化药销售额超250亿元，同比增长7.75%。康方提前泄密两款双抗的医保价3. 口服靶向治疗药物齐鲁制药 伊鲁阿克片：ALK阳性非小细胞肺癌全线适应症纳入医保。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611104116a4a2c893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611104116a4a2c893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU2236285917.USD","600789","AZN","BK4007","BK4588","LU2456880835.USD","LU0106261612.USD","LU0012050646.USD","01801","LU1169589451.USD","LU0205194284.USD","09926","LU2462157665.USD","LU1169590202.USD","BK4568","HAE","688331","LU2417539215.USD","01877","BK4198","BK4585","IE00BLDYK493.USD","IE00B64QTZ34.USD","688180","LU0320765992.SGD","TAK","LU0889565916.HKD","09995","LU0205193047.USD","LU1829250122.USD"],"gpt_icon":0},{"id":"2537993033","title":"JMP Securities重申美国血液技术评级为跑赢大盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2537993033","media":"同花顺iNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537993033?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:10","pubTimestamp":1747843809,"startTime":"0","endTime":"0","summary":"5月20日，JMP Securities重申美国血液技术评级为跑赢大盘，最新目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522001517a48708e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522001517a48708e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JMP","HAE"],"gpt_icon":0},{"id":"2536343815","title":"美国血液技术2025财年实现净利润1.68亿美元，同比增加42.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536343815","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536343815?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:00","pubTimestamp":1747411258,"startTime":"0","endTime":"0","summary":"5月17日，美国血液技术公布财报，公告显示公司2025财年净利润为1.68亿美元，同比增加42.37%；其中营业收入为13.61亿美元，同比增加3.97%，每股基本收益为3.33美元。从资产负债表来看，美国血液技术总负债16.30亿美元，其中短期债务3.04亿美元，资产负债比为1.51，流动比率为1.62。机构评级：截至2025年5月17日，当前有10家机构对美国血液技术目标价做出预测，其中目标均价为91.10美元，其中最低目标价为68.00美元，最高目标价为108.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000549a6e1db0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000549a6e1db0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE"],"gpt_icon":0},{"id":"2534430004","title":"雷蒙德詹姆斯公司：重申Haemonetics(HAE.US)评级，由强烈买入调整至强烈买入评级, 目标价由115.00美元调整至105.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534430004","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534430004?lang=zh_cn&edition=full","pubTime":"2025-05-10 00:26","pubTimestamp":1746807978,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司：重申Haemonetics(HAE.US)评级，由强烈买入调整至强烈买入评级, 目标价由115.00美元调整至105.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10002650280965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HAE"],"gpt_icon":0},{"id":"2534061168","title":"Needham：维持Haemonetics(HAE.US)评级，由买入调整至买入评级, 目标价由104.00美元调整至84.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534061168","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534061168?lang=zh_cn&edition=full","pubTime":"2025-05-09 03:02","pubTimestamp":1746730963,"startTime":"0","endTime":"0","summary":"Needham：维持Haemonetics(HAE.US)评级，由买入调整至买入评级, 目标价由104.00美元调整至84.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09030250242837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HAE"],"gpt_icon":0},{"id":"1108626591","title":"异动解读 | 美国血液技术盘中大涨5.04%，季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1108626591","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108626591?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:24","pubTimestamp":1746714280,"startTime":"0","endTime":"0","summary":"美国血液技术今日盘中大涨5.04%，引起市场广泛关注。这波涨势主要受到公司最新公布的季度财报超出市场预期的推动。据报道，Haemonetics公布的截至2025年3月31日的季度调整后每股收益为1.24美元，高于分析师平均预期的1.22美元，同时也远超去年同期的0.90美元。公司季度营收达到3.306亿美元，略高于分析师预期的3.2938亿美元，尽管同比下降了3.7%。值得注意的是，华尔街分析师对Haemonetics保持积极态度。这些积极因素共同推动了今日Haemonetics股价的强劲表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 美国血液技术盘中大涨5.04%，季度业绩超预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"2533394431","title":"美国血液技术盘中异动 早盘快速拉升5.04%报67.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533394431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533394431?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:49","pubTimestamp":1746712144,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时49分，美国血液技术股票出现波动，股价大幅上涨5.04%。截至发稿，该股报67.49美元/股，成交量5.7974万股，换手率0.12%，振幅3.21%。美国血液技术股票所在的医疗器械行业中，整体涨幅为0.31%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821490494f0935a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821490494f0935a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0106261612.USD","LU0205193047.USD","HAE","LU0205194284.USD","IE00BLDYK493.USD","LU0012050646.USD","LU1169589451.USD","LU1169590202.USD","BK4198","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2514086737","title":"美国血液技术盘中异动 下午盘急速上涨5.00%报66.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514086737?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:53","pubTimestamp":1740426800,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时53分，美国血液技术股票出现异动，股价快速拉升5.00%。截至发稿，该股报66.17美元/股，成交量38.3166万股，换手率0.76%，振幅5.12%。美国血液技术股票所在的医疗设备行业中，整体涨幅为0.25%。其相关个股中，Anbio Biotechnology、奥瑞许科技、美国血液技术涨幅较大，Sharps Technology Inc.、Glucotrack, Inc.、Microbot Medical Inc.较为活跃，换手率分别为44.95%、6.01%、5.07%，振幅较大的相关个股有Sharps Technology Inc.、Nexgel Inc C/Wts 27/12/2026 、Precision Optics Corporation, Inc.，振幅分别为23.85%、15.98%、14.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035320a25257e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035320a25257e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0205193047.USD","IE00B64QTZ34.USD","LU0106261612.USD","BK4198","LU0205194284.USD","LU1169590202.USD","LU1169589451.USD","LU0012050646.USD","HAE","IE00BLDYK493.USD"],"gpt_icon":0},{"id":"1155255330","title":"异动解读 | 美国血液技术公司股价盘中大跌5.25% 分析师下调评级预期所致","url":"https://stock-news.laohu8.com/highlight/detail?id=1155255330","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155255330?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:26","pubTimestamp":1738956391,"startTime":"0","endTime":"0","summary":"美国血液技术公司今日盘中股价大跌5.25%,引发了市场的广泛关注。根据相关新闻报道,导致该公司股价下跌的主要原因是分析师对其未来前景的预期下调。知名投资银行摩根大通证券公司今日维持了对美国血液技术的\"优于大市\"评级,但将公司的目标股价从125美元下调至100美元。美国血液技术公司主要从事血液和血浆成分采集、加工和输送,业务分为血浆、血液中心和医院三个分部。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 美国血液技术公司股价盘中大跌5.25% 分析师下调评级预期所致","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"2509778144","title":"美国血液技术盘中异动 下午盘大幅跳水5.06%报59.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509778144?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:15","pubTimestamp":1738955721,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时15分，美国血液技术股票出现波动，股价快速下跌5.06%。截至发稿，该股报59.80美元/股，成交量146.523万股，换手率2.92%，振幅6.33%。美国血液技术股票所在的医疗设备行业中，整体跌幅为0.68%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208031521a23d5d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208031521a23d5d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE","LU0205194284.USD","LU1169589451.USD","LU0012050646.USD","LU1169590202.USD","LU0106261612.USD","LU0205193047.USD","IE00B64QTZ34.USD","IE00BLDYK493.USD","BK4198"],"gpt_icon":0},{"id":"2509729791","title":"摩根大通证券公司：维持Haemonetics(HAE.US)评级，由优于大市调整至优于大市评级, 目标价由125.00美元调整至100.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509729791","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509729791?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:02","pubTimestamp":1738947740,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Haemonetics(HAE.US)评级，由优于大市调整至优于大市评级, 目标价由125.00美元调整至100.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08010248031451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159848","HAE","399975"],"gpt_icon":0},{"id":"2509572976","title":"雷蒙德詹姆斯公司：重申Haemonetics(HAE.US)评级，由强烈买入调整至强烈买入评级, 目标价由120.00美元调整至115.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509572976","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509572976?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:02","pubTimestamp":1738947740,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司：重申Haemonetics(HAE.US)评级，由强烈买入调整至强烈买入评级, 目标价由120.00美元调整至115.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08010248031449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HAE"],"gpt_icon":0},{"id":"1111478372","title":"异动解读 | 美国血液技术因下调业绩预期 盘中一度大跌近11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111478372","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111478372?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:42","pubTimestamp":1738856552,"startTime":"0","endTime":"0","summary":"美国医疗设备制造商美国血液技术(HAE)2月6日盘中一度大跌10.74%,引发市场关注。\n\n公司当天公布下调了2025财年的预期销售增长率,从此前的5%-8%下调至3%-5%,这是导致该股大跌的主因。同时,公司第三季度的营收3.49亿美元也低于分析师预期的3.53亿美元。\n\n美国血液技术主营业务包括血液和血浆成分采集、外科手术室和医院输血服务等。公司去年第三季度每股利润1.19美元高于市场预期,但由于业绩预期的下调,导致投资者对其长期增长前景持谨慎态度。该股过去12个月股价已下跌约17%。机构评级显示,82%的分析师给予买入评级,主要看好其血浆和医院业务增长潜力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HAE"],"gpt_icon":0},{"id":"2509774312","title":"美国血液技术盘中异动 急速下跌8.80%报64.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509774312?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852370,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，美国血液技术股票出现波动，股价快速下挫8.80%。截至发稿，该股报64.97美元/股，成交量2.4341万股，换手率0.05%，振幅1.01%。美国血液技术股票所在的医疗设备行业中，整体跌幅为0.19%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223250a23bce9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223250a23bce9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0106261612.USD","HAE","LU1169589451.USD","IE00B64QTZ34.USD","LU0205193047.USD","LU0205194284.USD","LU1169590202.USD","LU0012050646.USD","BK4198","IE00BLDYK493.USD"],"gpt_icon":0},{"id":"1104450572","title":"Haemonetics 2025年第三季度调整后每股收益$1.19超出预期$1.17，销售额$3.49亿低于预期$3.5293亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1104450572","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104450572?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:26","pubTimestamp":1738841182,"startTime":"0","endTime":"0","summary":"Haemonetics报告季度每股收益为$1.19，高于分析师预期的$1.17，比预期高出1.71%。这是比去年同期每股收益$1.04增加了14.42%。公司报告季度销售额为$3.49亿，低于分析师预期的$3.5293亿，低1.11%。以上内容来自Benzinga Earnings专栏，原文如下：Haemonetics  reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.17 by 1.71 percent. This is a 14.42 percent increase over earnings of $1.04 per share from the same period last year.  The company reported quarterly sales of $349.00 million which missed the analyst consensus estimate of $352.93 million by 1.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Haemonetics 2025年第三季度调整后每股收益$1.19超出预期$1.17，销售额$3.49亿低于预期$3.5293亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE"],"gpt_icon":0},{"id":"2509499545","title":"美国血液技术盘中异动 临近收盘急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509499545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509499545?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:39","pubTimestamp":1738701572,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时39分，美国血液技术股票出现波动，股价大幅上涨5.08%。截至发稿，该股报69.51美元/股，成交量64.9685万股，换手率1.29%，振幅5.19%。美国血液技术股票所在的医疗设备行业中，整体涨幅为0.06%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205043932abc26b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205043932abc26b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B64QTZ34.USD","LU0205194284.USD","LU1169590202.USD","LU0012050646.USD","BK4198","HAE","LU0106261612.USD","LU1169589451.USD","LU0205193047.USD","IE00BLDYK493.USD"],"gpt_icon":0},{"id":"2503916280","title":"美国血液技术盘中异动 早盘急速下跌5.00%报71.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503916280?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:52","pubTimestamp":1737039121,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时52分，美国血液技术股票出现异动，股价大幅下跌5.00%。截至发稿，该股报71.30美元/股，成交量7.6882万股，换手率0.15%，振幅4.88%。美国血液技术股票所在的医疗设备行业中，整体跌幅为0.29%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225201abad54a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225201abad54a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","LU0106261612.USD","LU0205193047.USD","LU0205194284.USD","IE00B64QTZ34.USD","HAE","LU1169590202.USD","LU1169589451.USD","IE00BLDYK493.USD","LU0012050646.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.haemonetics.com","stockEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":0.0782},{"period":"3month","weight":0.2448},{"period":"6month","weight":-0.0273},{"period":"1year","weight":-0.1118},{"period":"ytd","weight":-0.027}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Haemonetics Corporation1971年根据马萨诸塞州的法律注册成立，是一个全球性医疗设备公司,致力于为客户提供创新的血液管理解决方案——血浆来源收集者,采血机构和医院,在输血行业医疗设备系统方面有着强大的品牌优势,为客户提供解决方案的同时还提供信息技术平台和增值服务,其解决方案帮助患者改善临床结果，并提高血液中的供应链效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.441176,"avgChangeRate":-0.017038},{"month":2,"riseRate":0.441176,"avgChangeRate":-0.01304},{"month":3,"riseRate":0.676471,"avgChangeRate":0.021348},{"month":4,"riseRate":0.470588,"avgChangeRate":-0.02463},{"month":5,"riseRate":0.529412,"avgChangeRate":0.017651},{"month":6,"riseRate":0.6,"avgChangeRate":0.021703},{"month":7,"riseRate":0.685714,"avgChangeRate":0.018784},{"month":8,"riseRate":0.735294,"avgChangeRate":0.029718},{"month":9,"riseRate":0.529412,"avgChangeRate":0.016681},{"month":10,"riseRate":0.5,"avgChangeRate":-0.006116},{"month":11,"riseRate":0.529412,"avgChangeRate":0.029908},{"month":12,"riseRate":0.588235,"avgChangeRate":0.02413}],"exchange":"NYSE","name":"美国血液技术","nameEN":"Haemonetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美国血液技术,HAE,美国血液技术股票,美国血液技术股票老虎,美国血液技术股票老虎国际,美国血液技术行情,美国血液技术股票行情,美国血液技术股价,美国血液技术股市,美国血液技术股票价格,美国血液技术股票交易,美国血液技术股票购买,美国血液技术股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}